Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A0A3S7X379
Term | Name | Level | Count |
---|---|---|---|
GO:0009987 | cellular process | 1 | 9 |
GO:0016043 | cellular component organization | 3 | 9 |
GO:0030030 | cell projection organization | 4 | 9 |
GO:0071840 | cellular component organization or biogenesis | 2 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.521 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.521 |
CLV_PCSK_SKI1_1 | 28 | 32 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.589 |
DEG_MDM2_SWIB_1 | 90 | 97 | PF02201 | 0.381 |
DOC_CYCLIN_RxL_1 | 97 | 107 | PF00134 | 0.582 |
DOC_MAPK_MEF2A_6 | 12 | 21 | PF00069 | 0.673 |
DOC_PP1_RVXF_1 | 98 | 105 | PF00149 | 0.582 |
DOC_SPAK_OSR1_1 | 103 | 107 | PF12202 | 0.582 |
LIG_14-3-3_CanoR_1 | 12 | 17 | PF00244 | 0.725 |
LIG_14-3-3_CanoR_1 | 58 | 63 | PF00244 | 0.355 |
LIG_Actin_WH2_2 | 89 | 105 | PF00022 | 0.437 |
LIG_FHA_1 | 127 | 133 | PF00498 | 0.387 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.474 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.515 |
LIG_FHA_2 | 145 | 151 | PF00498 | 0.362 |
LIG_LIR_Gen_1 | 68 | 77 | PF02991 | 0.352 |
LIG_LIR_Gen_1 | 84 | 93 | PF02991 | 0.366 |
LIG_LIR_Nem_3 | 15 | 21 | PF02991 | 0.641 |
LIG_LIR_Nem_3 | 68 | 74 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 84 | 89 | PF02991 | 0.345 |
LIG_Pex14_1 | 136 | 140 | PF04695 | 0.254 |
LIG_Pex14_1 | 39 | 43 | PF04695 | 0.474 |
LIG_Pex14_2 | 86 | 90 | PF04695 | 0.348 |
LIG_SH2_PTP2 | 71 | 74 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.340 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.674 |
LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.318 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.705 |
LIG_SH3_3 | 27 | 33 | PF00018 | 0.582 |
LIG_SUMO_SIM_par_1 | 1 | 7 | PF11976 | 0.629 |
LIG_SUMO_SIM_par_1 | 119 | 125 | PF11976 | 0.437 |
MOD_CK2_1 | 144 | 150 | PF00069 | 0.362 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.448 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.423 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.347 |
MOD_N-GLC_2 | 79 | 81 | PF02516 | 0.474 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.387 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.365 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.450 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.362 |
MOD_NEK2_2 | 126 | 131 | PF00069 | 0.388 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.686 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.690 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.357 |
MOD_PKA_2 | 57 | 63 | PF00069 | 0.346 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.489 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.465 |
MOD_Plk_4 | 82 | 88 | PF00069 | 0.337 |
TRG_DiLeu_BaLyEn_6 | 17 | 22 | PF01217 | 0.688 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.649 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.324 |
TRG_ER_diArg_1 | 11 | 13 | PF00400 | 0.723 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KEE0 | Bodo saltans | 39% | 100% |
A0A1X0P1Z3 | Trypanosomatidae | 49% | 100% |
A0A3R7MXG9 | Trypanosoma rangeli | 52% | 100% |
A4I5E9 | Leishmania infantum | 100% | 100% |
C9ZQT6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9B0P7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4Q7I5 | Leishmania major | 93% | 100% |